Log In
BCIQ
Print this Print this
 

ELB401 (formerly TG3003)

  Manage Alerts
Collapse Summary General Information
Company Transgene S.A.
DescriptionHuman mAb against CD115
Molecular Target Colony-stimulating factor 1 receptor (CSF1R) (C-FMS) (CD115)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerElsaLys Biotech

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$9.7M

$9.7M

0


 Deals Details
Get a free BioCentury trial today